Avyxa Holdings Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVYXA HOLDINGS, and when can generic versions of AVYXA HOLDINGS drugs launch?
AVYXA HOLDINGS has one approved drug.
There is one US patent protecting AVYXA HOLDINGS drugs.
There are seven patent family members on AVYXA HOLDINGS drugs in five countries and three supplementary protection certificates in three countries.
Summary for Avyxa Holdings
| International Patents: | 7 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Avyxa Holdings
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avyxa Holdings | DOCETAXEL | docetaxel | SOLUTION;INTRAVENOUS | 215813-001 | Nov 22, 2022 | DISCN | Yes | No | 10,398,785 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Avyxa Holdings | DOCETAXEL | docetaxel | SOLUTION;INTRAVENOUS | 215813-003 | Nov 22, 2022 | DISCN | Yes | No | 10,398,785 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Avyxa Holdings | DOCETAXEL | docetaxel | SOLUTION;INTRAVENOUS | 215813-002 | Nov 22, 2022 | DISCN | Yes | No | 10,398,785 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Avyxa Holdings Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2016149162 | ⤷ Try a Trial |
| Japan | 2018512395 | ⤷ Try a Trial |
| Poland | 3270912 | ⤷ Try a Trial |
| China | 107427486 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Avyxa Holdings Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0253738 | C960002 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DOCETAXEL, DESGEWENST IN DE VORM VAN EEN TRIHYDRAAT; REGISTRATION NO/DATE: EU/1/95/002/001 - EU/1/95/002/002 19951127 |
| 1667986 | 28/2013 | Austria | ⤷ Try a Trial | PRODUCT NAME: DIMETHOXYDOCETAXEL-ACETONSOLVAT (CABAZITAXEL-ACETONSOLVAT); REGISTRATION NO/DATE: EU/1/11/676/001 20110317 |
| 1667986 | 92172 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL) |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
